U.S. Fluid Management Systems Market Size & Share Analysis - Trends, Drivers, Competitive Landscape, and Forecasts (2024

Description

List of Tables

The U.S. fluid management systems market is projected to grow from $2,324.3 million in 2024 to $4,194.5 million by 2030, registering a compound annual growth rate (CAGR) of 10.6%. This growth is fueled by the increasing prevalence of chronic conditions such as diabetes and end-stage renal disease, which require advanced surgical and diagnostic procedures. Additionally, the rising adoption of minimally invasive surgeries, which demand precise fluid regulation, is driving the market forward. Technological innovations, such as automated systems and real-time fluid monitoring, are enhancing operational efficiency and safety, further propelling the adoption of fluid management solutions.

Key Insights

The rising adoption of minimally invasive procedures, offering faster recovery times and reduced complications, is driving demand for advanced fluid management systems.

Technological advancements, including automated fluid regulation and real-time monitoring, are improving surgical precision and patient outcomes.

Hospitals are the largest end-users, extensively deploying fluid management systems in various surgical procedures for enhanced patient care.

Ambulatory surgery centers are increasingly adopting fluid management systems to cater to the growing demand for outpatient surgical procedures.

Fluid management systems play a crucial role in urology and nephrology procedures, ensuring precise fluid regulation and patient safety.

The increasing prevalence of chronic diseases, such as diabetes and kidney disorders, is significantly boosting the demand for fluid management systems in surgical and diagnostic applications.

Favorable government policies and reimbursement schemes are encouraging healthcare providers to invest in advanced fluid management technologies.

The market is characterized by intense competition, with companies focusing on innovation to address evolving clinical demands.

Regulatory compliance and patient safety standards are driving healthcare facilities to upgrade to advanced fluid management solutions.

Continuous research and development activities are expected to lead to new product launches and expanded applications in the coming years.

Product Code: 13175

Chapter 1. Research Background

1.1 Research Objectives
1.2 Market Definition
1.3 Analysis Period
1.4 Market Data Reporting Unit
- 1.4.1 Value
1.5 Market Size Breakdown by Segment
- 1.5.1 Market Segmentation by Product Type
- 1.5.2 Market Segmentation by End User
- 1.5.3 Market Segmentation by Application
1.6 Key Stakeholders

Chapter 2. Research Methodology

2.1 Secondary Research
- 2.1.1 Paid
- 2.1.2 Unpaid
- 2.1.3 P&S Intelligence Database
2.2 Primary Research
- 2.2.1 Breakdown of Primary Research, by Industry Participant
- 2.2.2 Breakdown of Primary Research, by Designation
- 2.2.3 Breakdown of Primary Research, by Company Type
2.3 Market Size Estimation
2.4 Data Triangulation
2.5 Notes and Caveats

Chapter 3. Executive Summary

Chapter 4. Market Indicators

4.1 Prevalence of Chronic Diseases
4.2 Emergency Department Visits
4.3 Number of Endoscopists
4.4 Number of Hospitals State-Wise
4.5 Number of Endoscopy Centers in U.S. States

Chapter 5. Industry Outlook

5.1 Market Dynamics
- 5.1.1 Trends
  - 5.1.1.1 Increasing adoption of minimally invasive procedures
  - 5.1.1.2 Shift toward disposable accessories
- 5.1.2 Drivers
  - 5.1.2.1 Technological advancements
  - 5.1.2.2 Rising prevalence of chronic diseases
  - 5.1.2.3 Growing investment in healthcare infrastructure improvement
  - 5.1.2.4 Government Initiatives and reimbursements
- 5.1.3 Impact Analysis of Drivers on Market Forecast
- 5.1.4 Restraints
  - 5.1.4.1 High cost of advanced systems
  - 5.1.4.2 Lack of skilled professionals
- 5.1.5 Impact Analysis of Restraints on Market Forecast
5.2 Impact of COVID-19
5.3 Porter's Five Forces Analysis
- 5.3.1 Bargaining Power of Buyers
- 5.3.2 Bargaining Power of Suppliers
- 5.3.3 Intensity of Rivalry
- 5.3.4 Threat of New Entrants
- 5.3.5 Threat of Substitutes

Chapter 6. U.S. Market Size and Forecast

6.1 Overview
6.2 Market Revenue, by Product Type (2017-2030)
6.3 Market Revenue, by Application (2017-2030)
6.4 Market Revenue, by End User (2017-2030)

Chapter 7. Integrated Systems: Advantages and Market Potential

Chapter 8. Competitive Landscape

8.1 List of Major Market Players and Their Offerings
8.2 Strategic Developments of Key Players
- 8.2.1 Product Launches and Approvals
- 8.2.2 Mergers and Acquisitions
- 8.2.3 Partnerships and Collaborations
- 8.2.4 Other Developments

Chapter 9. Company Profiles

9.2 Olympus Corporation of the Americas
- 9.2.1 Business Overview
- 9.2.2 Product and Service Offerings
9.3 Boston Scientific Corporation
- 9.3.1 Business Overview
- 9.3.2 Product and Service Offerings
- 9.3.3 Key Financial Summary
9.4 KARL STORZ SE & Co. KG
- 9.4.1 Business Overview
- 9.4.2 Product and Service Offerings
9.5 CONMED Corporation
- 9.5.1 Business Overview
- 9.5.2 Product and Service Offerings
- 9.5.3 Key Financial Summary
9.6 Smith & Nephew Inc.
- 9.6.1 Business Overview
- 9.6.2 Product and Service Offerings
9.7 Medtronic plc
- 9.7.1 Business Overview
- 9.7.2 Product and Service Offerings
- 9.7.3 Key Financial Summary
9.8 Stryker Corporation
- 9.8.1 Business Overview
- 9.8.2 Product and Service Offerings
- 9.8.3 Key Financial Summary
9.9 B. Braun SE
- 9.9.1 Business Overview
- 9.9.2 Product and Service Offerings
- 9.9.3 Key Financial Summary
9.10 Arthrex Inc.
- 9.10.1 Business Overview
- 9.10.2 Product and Service Offerings
9.11 Molnlycke Health Care AB
- 9.11.1 Business Overview
- 9.11.2 Product and Service Offerings
- 9.11.3 Key Financial Summary
9.12 STERIS Corporation
- 9.12.1 Business Overview
- 9.12.2 Product and Service Offerings
9.13 Cardinal Health Inc.
- 9.13.1 Business Overview
- 9.13.2 Product and Service Offerings
- 9.13.3 Key Financial Summary
9.14 Teleflex Incorporated
- 9.14.1 Business Overview
- 9.14.2 Product and Service Offerings
- 9.14.3 Key Financial Summary
9.15 Meditrina, Inc.
- 9.15.1 Business Overview
- 9.15.2 Product and Service Offerings
9.16 Terumo Americas Holding Inc.
- 9.16.1 Business Overview
- 9.16.2 Product and Service Offerings
9.18 Fresenius Medical Care Holdings Inc.
- 9.18.1 Business Overview
- 9.18.2 Product and Service Offerings
- 9.18.3 Key Financial Summary
9.19 3M Company
- 9.19.1 Business Overview
- 9.19.2 Product and Service Offerings
- 9.19.3 Key Financial Summary
9.20 Nipro Medical Corporation
- 9.20.1 Business Overview
- 9.20.2 Product and Service Offerings
9.21 Asahi Kasei America Inc.
- 9.21.1 Business Overview
- 9.21.2 Product and Service Offerings
9.22 NIKKISO AMERICA INC.
- 9.22.1 Business Overview
- 9.22.2 Product and Service Offerings
9.23 Toray Industries Inc.
- 9.23.1 Business Overview
- 9.23.2 Product and Service Offerings
9.24 COOK MEDICAL LLC
- 9.24.1 Business Overview
- 9.24.2 Product and Service Offerings
9.26 Becton, Dickinson and Company
- 9.26.1 Business Overview
- 9.26.2 Product and Service Offerings
- 9.26.3 Key Financial Summary
9.27 Baxter International Inc.
- 9.27.1 Business Overview
- 9.27.2 Product and Service Offerings
- 9.27.3 Key Financial Summary
9.28 Zimmer Biomet Holdings Inc.
- 9.28.1 Business Overview
- 9.28.2 Product and Service Offerings
- 9.28.3 Key Financial Summary
9.29 Erbe Elektromedizin GmbH
- 9.29.1 Business Overview
- 9.29.2 Product and Service Offerings
9.30 JMS North America Corporation
- 9.30.1 Business Overview
- 9.30.2 Product and Service Offerings
9.31 Barkey Corporation
- 9.31.1 Business Overview
- 9.31.2 Product and Service Offerings
9.32 CAREstream Medical Ltd.
- 9.32.1 Business Overview
- 9.32.2 Product and Service Offerings
9.33 Richard Wolf Medical Instruments Corporation
- 9.33.1 Business Overview
- 9.33.2 Product and Service Offerings

Chapter 10. Appendix

10.1 Sources and References
10.2 Related Reports